Charles L. Berman

Statistics

Publications

Citations

3.2K

H-Index

Active since

1935

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Hackensack University Medical Center

United States Military Academy

Fairleigh Dickinson University

Columbia University

Charles L. Berman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in 5-alpha-reductase inhibition, dentistry, and medicine.

Publications per year

1935–2004

Publications

The Excessive Loss of Branemark Fixtures in Type IV Bone: A 5‐Year Analysis

Robert A. Jaffin, Charles L. Berman · Journal of Periodontology · 1991 · 1.1K citations

Dentistry, Periodontology, Bone Grafting +11

Primary Carcinoma of The Liver

Charles L. Berman · Advances in cancer research · 1958 · 393 citations

Medicine, Oncology, Pathology +17

Azasteroids: structure-activity relationships for inhibition of 5.alpha.-reductase and of androgen receptor binding

Gary H. Rasmusson, G.F. Reynolds, N. G. Steinberg et al. · Journal of Medicinal Chemistry · 1986 · 254 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Immediate Loading of Implants in Partially and Fully Edentulous Jaws: A Series of 27 Case Reports

Robert A. Jaffin, A Kumar, Charles L. Berman · Journal of Periodontology · 2000 · 210 citations

Dentistry, Implant Dentistry, Restorative Dentistry +11

Response of Rat Ventral Prostate to a New and Novel 5αa-Reductase Inhibitor

J. R. Brooks, E.M. Baptista, Charles L. Berman et al. · Endocrinology · 1981 · 145 citations

Life Sciences, Endocrinology, Pharmacology +17

1–5 of 27